- Titre
- Engineering Peptide Inhibitors To Overcome PDZ Binding Promiscuity
- Créateurs - sans rôle
- Lars Vouilleme - Charite, Inst Med Immunol, D-10115 Berlin, GermanyPatrick R. Cushing - Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USARudolf Volkmer - Charité - Universitätsmedizin BerlinDean R. Madden - Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USAPrisca Boisguerin - Charite, Inst Med Immunol, D-10115 Berlin, Germany
- Détails de publication
- Angewandte Chemie International Edition, Vol.49(51), pp.9912-9916
- Éditeur
- Wiley
- Nombre de pages
- 5
- Note de subvention
- R01-DK075309 / NIH, NIDDK; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) German cystic fibrosis association Charite-Habilitationsstipendium MADDEN06P0; STANTO97R0 / Cystic Fibrosis Foundation S05/08 / Mukoviszidose e.V. T32-GM008704 / NIH, NIGMS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS) VO 885/3 2 / Deutsche Forschungsgemeinschaft (DFG); German Research Foundation (DFG) P20-RR018787 / NIH, NCRR; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Research Resources (NCRR)
- Identifiants
- 99148848409311
- Unité académique
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Engineering Peptide Inhibitors To Overcome PDZ Binding Promiscuity
Angewandte Chemie International Edition, Vol.49(51), pp.9912-9916
17/12/2010
PMID: 21105032
Indicateurs
1 Consultations de la notice